Sign In  |  Register  |  About San Anselmo  |  Contact Us

San Anselmo, CA
September 01, 2020 1:33pm
7-Day Forecast | Traffic

  • Search Hotels in San Anselmo

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Bristol-Myers Squibb (NY: BMY )

44.11 -0.44 (-0.99%)
Official Closing Price Updated: 7:00 PM EDT, May 16, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 15,765,793
Open 44.47
Bid (Size) 44.06 (2)
Ask (Size) 44.18 (9)
Prev. Close 44.55
Today's Range 43.68 - 44.53
52wk Range 43.33 - 66.38
Shares Outstanding 2,222,113,553
Dividend Yield 5.17%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Walmart Earnings And The State Of The Consumer
​​​​​​​This earnings season showed a notable acceleration in the earnings growth pace, which produces a reassuring earnings backdrop for the market. 
Via Talk Markets
FDA Approves Expanded Use Of Bristol Myers Squibb's Breyanzi Cancer Cell Therapy For Previously Treated Follicular Lymphoma
FDA grants accelerated approval for Bristol Myers Squibb's Breyanzi, a CAR T cell therapy, for relapsed or refractory follicular lymphoma. Breyanzi is included in NCCN guidelines and shows high... 
Via Benzinga
Exposures Product Safety

Performance

YTD
-16.39%
-16.39%
1 Month
-8.60%
-8.60%
3 Month
-10.78%
-10.78%
6 Month
-13.24%
-13.24%
1 Year
-31.79%
-31.79%

More News

Read More
New Four-Year Sotyktu (deucravacitinib) Data Demonstrate Durable Response Rates and Consistent Safety in Moderate-to-Severe Plaque Psoriasis
From Bristol Myers Squibb
Via Business Wire
7 Pharma Stocks Harnessing AI Brainpower for Big Breakthroughs
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence
Is Bristol Myers' Dividend in Danger?
Via The Motley Fool
2 Beaten-Down Stocks to Buy and Hold for 10 Years
Via The Motley Fool
Bristol Myers Squibb’s CAR T Cell Therapy Breyanzi Approved by the U.S. Food and Drug Administration for Relapsed or Refractory Follicular Lymphoma
From Bristol Myers Squibb
Via Business Wire
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Dividend Capture Captains: The 3 Best Blue-Chip Stocks for Tactical Traders
Via InvestorPlace
Cytokinetics Reveals More From The Study That Boosted Shares 83% In A Day
Via Investor's Business Daily
Down but Not Out: 3 Stocks to Buy on a Post-Earnings Dip
Via The Motley Fool
Bristol Myers Squibb Provides Update on Phase 3 CheckMate -73L Trial
From Bristol Myers Squibb
Via Business Wire
Bounce Alert: 3 Large Caps With RSIs Too Good To Ignore
Via MarketBeat
Topics Economy
Exposures Interest Rates
What's Going On With Medical Therapeutic Firm Aethlon Medical On Friday?
Via Benzinga
Catalyst's New CEO Has Big Ideas For The Small Biotech
Via Investor's Business Daily
Wall Street's Most Accurate Analysts' Views On 3 Health Care Stocks With Over 5% Dividend Yields
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Top 4 Health Care Stocks Which Could Rescue Your Portfolio This Month
Via Benzinga
Bristol Myers Squibb to Participate in Upcoming Investor Conferences
From Bristol Myers Squibb
Via Business Wire
Maximize Your Dividends: 7 Stocks Trading Under $50 with 5%+ Yields
Via InvestorPlace
U.S. Food and Drug Administration Accepts Bristol Myers Squibb’s Application for Subcutaneous Nivolumab (nivolumab and hyaluronidase)
From Bristol Myers Squibb
Via Business Wire
European Medicines Agency Validates Bristol Myers Squibb’s Application for Opdivo (nivolumab) Plus Yervoy (ipilimumab) for the First-Line Treatment of Adult Patients with Microsatellite...
From Bristol Myers Squibb
Via Business Wire
Uncover the Potential: 3 Discounted Stocks Ready for a Comeback
Via InvestorPlace
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 SanAnselmo.com & California Media Partners, LLC. All rights reserved.